Ingevity (NYSE:NGVT – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41, FiscalAI reports. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity updated its FY 2026 guidance to 5.000-5.450 EPS.
Ingevity Price Performance
Shares of NYSE NGVT traded down $1.34 during trading hours on Thursday, reaching $69.28. 190,545 shares of the stock traded hands, compared to its average volume of 293,758. The company’s 50-day simple moving average is $71.53 and its two-hundred day simple moving average is $70.91. The company has a market capitalization of $2.41 billion, a P/E ratio of -19.40 and a beta of 1.16. Ingevity has a 52-week low of $39.74 and a 52-week high of $79.29. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83.
Insider Transactions at Ingevity
In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.88% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Ingevity
Wall Street Analysts Forecast Growth
Several research firms have weighed in on NGVT. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $80.00.
Check Out Our Latest Stock Report on NGVT
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Stories
- Five stocks we like better than Ingevity
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
- Tesla: After a Rough Quarter, 2 Very Different Futures Come Into Focus
- Why NXP Semiconductors Could Be the AI Stock Everyone Is Missing
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
